Cover Image

Serious limitations of the current strategy to control Soil-Transmitted Helminths and added value of Ivermectin/Albendazole mass administration: A population-based observational study in Cameroon.

<h4>Background</h4>Soil-transmitted helminth (STH) infections remain a public health concern in sub-Saharan Africa. School-based mass drug administration (MDA) using the anthelminthic drug Mebendazole/Albendazole have succeeded in controlling morbidity associated to these diseases but fa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Linda Djune-Yemeli (Author), Hugues C Nana-Djeunga (Author), Cédric G Lenou-Nanga (Author), Cyrille Donfo-Azafack (Author), André Domche (Author), Floribert Fossuo-Thotchum (Author), Yannick Niamsi-Emalio (Author), Francine Ntoumi (Author), Joseph Kamgno (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2020-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
by: Linda Djune-Yemeli, et al.
Published: (2022)

High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination
by: Hugues C. Nana-Djeunga, et al.
Published: (2022)

Correction to: High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination
by: Hugues C. Nana-Djeunga, et al.
Published: (2022)

Egg excretion patterns of soil-transmitted helminth infections in humans following albendazole-ivermectin and albendazole treatment.
by: Sophie Welsche, et al.
Published: (2024)

Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: Results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania.
by: Ladina Keller, et al.
Published: (2021)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013)

Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.
by: Adriana Echazú, et al.
Published: (2017)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014)

Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis.
by: Marta S Palmeirim, et al.
Published: (2018)

Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
by: Khalfan A Mohammed, et al.
Published: (2008)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
by: Nicholas O Opoku, et al.
Published: (2023)

Progress towards global elimination of lymphatic filariasis
by: Joseph Kamgno, et al.
Published: (2020)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
by: Taniawati Supali, et al.
Published: (2021)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010)

Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
by: Purushothaman Jambulingam, et al.
Published: (2021)

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
by: Scott McPherson, et al.
Published: (2023)

Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
by: Yupin Suputtamongkol, et al.
Published: (2011)

A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.
by: Belizario V.Y, et al.
Published: (2003)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016)

Association between response to albendazole treatment and β-tubulin genotype frequencies in soil-transmitted helminths.
by: Aïssatou Diawara, et al.
Published: (2013)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
by: Jonathan Mnkai, et al.
Published: (2022)

Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
by: Arnauld Efon-Ekangouo, et al.
Published: (2023)

Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis.
by: Charles Whittaker, et al.
Published: (2022)

Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.
by: Mkunde Chachage, et al.
Published: (2014)

Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic.
by: Jozef Vercruysse, et al.
Published: (2011)

Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections.
by: Ana Lucia Moncayo, et al.
Published: (2008)

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study
by: Adam M. Fimbo, et al.
Published: (2024)

Perceptions and acceptability of co-administered albendazole, ivermectin and azithromycin mass drug administration, among the health workforce and recipient communities in Ethiopia.
by: Scott McPherson, et al.
Published: (2023)

Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR.
by: Phonepasong Ayé Soukhathammavong, et al.
Published: (2012)

Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial.
by: Peter Steinmann, et al.
Published: (2008)

Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.
by: Sammy M Njenga, et al.
Published: (2024)

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
by: Adam M. Fimbo, et al.
Published: (2022)

The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
by: Sébastien D S Pion, et al.
Published: (2020)

Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial
by: Lucy N John, et al.
Published: (2022)

Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d'Ivoire
by: Veshni Pillay-Fuentes Lorente, et al.
Published: (2024)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

Albendazole alone vs. albendazole and diethylcarbamazine combination therapy for trichuriasis
by: Windya Sari Nasution, et al.
Published: (2014)

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
by: Myra Hardy, et al.
Published: (2020)